Skin patch improves attention span in stroke patients
(Medical Xpress) -- Researchers at the UCL Institute of Neurology have found that giving the drug rotigotine as a skin patch can improve inattention in some stroke patients.
Neuroscience
Jul 04, 2012 |
not rated yet |
0
Atrial fibrillation: Flec-SL trial proves efficacy of short-term antiarrhythmic drug treatment
Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart. It affects several million people in Europe. AF causes a loss of contraction in the atria and gives rise to heart failure. Moreover, it is ...
Cardiology
Jun 18, 2012 |
not rated yet |
0
World's biggest stroke clot-buster trial reveals patient benefits
(Medical Xpress) -- Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment, new research has found.
Neuroscience
May 24, 2012 |
5 / 5 (1) |
0
Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms
People with bleeding brain aneurysms have the best chance of survival and full recovery if they receive aggressive emergency treatment from a specialized team at a hospital that treats a large number of patients like them ...
Cardiology
May 17, 2012 |
not rated yet |
0
Meta-analysis confirms benefit of statins in those with no previous history of vascular disease
Even people at low risk of heart problems would benefit from statins, cheap drugs that lower levels of ‘bad’ cholesterol in the blood.
Cardiology
May 16, 2012 |
not rated yet |
0
Speedier treatment and better outcomes for high volume stroke centers
Treatment is faster and outcomes are better at stroke centres dealing with a high volume of patients, finds research published online in the Journal of NeuroInterventional Surgery. ...
Surgery
May 09, 2012 |
not rated yet |
0
Mobile stroke unit roughly halves time to diagnosis and treatment of patients with suspected stroke
Using a specialised ambulance or mobile stroke unit (MSU) to assess and treat patients who have had a suspected stroke at the site of the emergency roughly halves the time from the initial call for help to treatment decision, ...
Cardiology
Apr 10, 2012 |
not rated yet |
0
Antipsychotic medication associated with modest heart attack risk in older patients with dementia
Antipsychotic medication was associated with a modest and time-limited increased risk of myocardial infarction (heart attack) among older patients treated with cholinesterase inhibitors for dementia, according to a study ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
Researchers discover drug target for stimulating recovery from stroke
Investigators at the Stanford University School of Medicine have shown that removing a matched set of molecules that typically help to regulate the brain's capacity for forming and eliminating connections between nerve cells ...
Neuroscience
Mar 21, 2012 |
5 / 5 (2) |
0
|
Scientists develop world's most advanced drug to protect the brain after a stroke
Scientists at the Toronto Western Research Institute (TWRI), Krembil Neuroscience Center, have developed a drug that protects the brain against the damaging effects of a stroke in a lab setting. This drug has been in development ...
Medical research
Feb 29, 2012 |
5 / 5 (1) |
0
|
Study looks at patients' decision-making in asymptomatic carotid stenosis
A paper from Rhode Island Hospital and Henry Ford Hospital in Detroit examines whether different presentation formats, presenter characteristics, and patient characteristics affect decision-making for patients requiring treatment ...
Neuroscience
Feb 22, 2012 |
5 / 5 (1) |
0
Dash to help - new app to improve stroke treatment
The Newcastle team who helped develop the FAST system to identify a stroke are now piloting an app to ensure the best treatment for stroke patients.
Health
Feb 17, 2012 |
not rated yet |
0
University of Kentucky offers stroke stem cell trial
The University of Kentucky will be the first site in the state and one of a select few in the entire country participating in the first stages of a groundbreaking study to investigate the effects of MultiStem, a human adult ...
Medical research
Jan 13, 2012 |
not rated yet |
0
Anti-clotting drug lowers risks in acute coronary syndrome treatment
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American ...
Cardiology
Nov 14, 2011 |
not rated yet |
0
|
New clue to brain bleeding after stroke treatment
The only medication currently approved for stroke treatment – tissue plasminogen activator (tPA), which dissolves blood clots – is associated with an increased risk of bleeding in the brain, particularly among patients ...
Neuroscience
Oct 17, 2011 |
not rated yet |
0
|
